http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007122485-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 |
filingDate | 2005-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2008-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2007122485-A |
titleOfInvention | KINASE INHIBITORS |
abstract | 1. The compound of formula Ia or Ib: where Ar is selected from the group consisting of aryl, substituted aryl, heteroaryl and substituted heteroaryl; W is selected from the group consisting of amino and substituted amino; X is selected from the group consisting of carboxyl, carboxyl esters and aminoacyl; Y is selected from the group consisting of oxygen, sulfur, —S (O) -, —S (O) -, and —NR—, where R is selected from the group consisting of hydrogen, alkyl, and substituted alkyl; each R is independently selected from a group consisting of hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, carboxyl, carboxyl x esters, aminoacyl, cycloalkyl, substituted cycloalkyl, halogen, cyano, nitro, hydroxyl, alkoxy, aryloxy, heteroaryloxy, heteroaryl, substituted heteroaryl, heterocyclic radical and substituted heterocyclic radical; R is selected from the group consisting of hydrogen and alkyl; R consisting of hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, amino, substituted amino, cycloalkyl, substituted cycloalkyl, cycloalkoxy, substituted cycloalkoxy, aryl, substituted aryl, aryloxy, substituted aryloxy, cycloalkyl, substituted cycloalkyl, cycloalkoxy, substituted cycloalkoxy, heteroaryl, substituted heteroaryl, heteroaryloxy, substituted heteroaryloxy, heterocyclic radical, substituted heterocyclic radical, heterocycloxy and substituted heterocycloxy; and n is an integer of 0, 1 or 2; or isomers, prodrugs or pharmaceutically acceptable salts thereof. 2. A compound according to claim 1, wherein Y is selected from the group consisting of —S—, —S (O) - and —S (O) -. 3. The compound according to claim 1 or 2, where W is amino. The compound according to claim 1, having |
priorityDate | 2004-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 105.